Mubariki, R.; Eiza, N.; Sabag, A.D.; Keret, S.; Rimar, D.; Slobodin, G.; Zisman, D.; Toubi, E.; Vadasz, Z.
Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. Int. J. Mol. Sci. 2025, 26, 11160.
https://doi.org/10.3390/ijms262211160
AMA Style
Mubariki R, Eiza N, Sabag AD, Keret S, Rimar D, Slobodin G, Zisman D, Toubi E, Vadasz Z.
Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences. 2025; 26(22):11160.
https://doi.org/10.3390/ijms262211160
Chicago/Turabian Style
Mubariki, Raeda, Nasren Eiza, Adi D. Sabag, Shiri Keret, Doron Rimar, Gleb Slobodin, Devy Zisman, Elias Toubi, and Zahava Vadasz.
2025. "Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis" International Journal of Molecular Sciences 26, no. 22: 11160.
https://doi.org/10.3390/ijms262211160
APA Style
Mubariki, R., Eiza, N., Sabag, A. D., Keret, S., Rimar, D., Slobodin, G., Zisman, D., Toubi, E., & Vadasz, Z.
(2025). Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences, 26(22), 11160.
https://doi.org/10.3390/ijms262211160